|
Lasmiditan as a Treatment for Organ Transplant Rejection
Lasmiditan is a drug currently used to treat migraines. However, University of Arizona researchers discovered that Lasmiditan induces mitochondrial biogenesis in mouse kidneys and restores renal function to mice subjected to kidney injury. Mitochondria have been identified as important therapeutic targets in the aftermath of organ transplantation. This...
Published: 10/2/2025
|
Inventor(s): Rick Schnellmann, Bekir Tanriover
Keywords(s):
Category(s): Technology Classifications > Life Sciences > Small Molecules, Technology Classifications > Healthcare Portfolios > Transplantation
|
